CO2 Solution Receives Power Plant Patent
Trading symbol: CST Outstanding shares: 50,261,136 Patent covering use of enzyme for carbon capture at coal fired power plants is fourth new patent received by CO2 Solution in 2009
This patent is the fourth new patent received by CO2 Solution during 2009, in addition to the following:
U.S. Patent 7,514,056 - Process and installation for the fractionation of air into specific gases; Protects the use of carbonic anhydrase for use in efficiently capturing CO2 from compressed air as part of an air- separation unit for the production of oxygen. The Company believes that the patent can address the cost challenge that conventional air- separation processes face due to ever increasing CO2 concentrations in ambient air. The specialty gas industry has shown interest in the patent and CO2 Solution intends to pursue possible commercialization opportunities therein. U.S. Patent 7,521,217 - Carbonic anhydrase having increased stability under high temperature conditions; Covers the Company's proprietary enzyme 'mutants' which have increased thermal and industrial stability through genetic engineering. Canadian Patent 2,443,222 - A process and plant for the production of Portland cement clinker (equivalent U.S. Patent 6,908,507); Covers the use of the enzyme for the capture of CO2 from cement plant flue gas and the production of calcium carbonate for reuse in the cement making process, and has the potential to materially reduce overall carbon emissions from the cement production process.
Regarding the issuance of these four new patents, Mr.
About CO2 Solution
CO2 Solution’s technology platform is protected by several North American and European patents, including the use of carbonic anhydrase for CO2 capture and release in a packed column system. News releases and additional information can be found at www.co2solution.com.
The TSX Venture Exchange has neither approved nor disapproved the information contained herein and accepts no responsibility for it.
SOURCE CO2 SOLUTION INC.